
Concizumab shows promise as a subcutaneous treatment option for hemophilia B with inhibitors, significantly reducing bleeding rates.


coremsg

The results are from the prospective, multicenter, phase 3 explorer7 trial, involving 133 patients, including 80 with hemophilia A and 53 had hemophilia B.

Hemophilia: Concizumab, a New Treatment Option?

concizumab-new-treatment-for-hemophilia-b-with-inhibitors


Concizumab: New Treatment for Hemophilia B with Inhibitors


title_rewrite


SGLT2 inhibitors can lead to false-positive alcohol tests due to microbial fermentation of urinary glucose.


A case raises the suggestion that sugars in the urine are fermented due to failure to keep the samples refrigerated.

SGLT2 Inhibitors: Cause of False-Positive Test Results?

sglt2-inhibitors-and-false-positive-alcohol-tests


SGLT2 Inhibitors and False-Positive Alcohol Tests



X線の内部構造を捉える新しい方法を提案する。


x-ray-3d-reconstruction-with-structure-aware-sparse-view-technology


X-ray 3D Reconstruction with Structure-Aware Sparse-View Technology
